Sciascia Thomas's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed Aug 16, 2024
- Accession no.
- 0000950170-24-098117
- Filed
- Aug 16, 2024
- Trade date
- Aug 14-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $87.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sciascia ThomasCIK 0001229946 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Common Stock | MOption exerciseAcquired | +100 | $1.43 | +$143 | 220,415 | Direct | |
| Aug 14, 2024 | Common Stock | SSaleDisposed | −100 | $2.75 | −$275 | 220,315 | Direct | |
| Aug 15, 2024 | Common Stock | MOption exerciseAcquired | +12,745 | $1.43 | +$18,225.35 | 233,060 | Direct | |
| Aug 15, 2024 | Common Stock | SSaleDisposed | −12,745 | $2.79 | −$35,558.55 | 220,315 | Direct | |
| Aug 16, 2024 | Common Stock | MOption exerciseAcquired | +18,660 | $1.43 | +$26,683.8 | 238,975 | Direct | |
| Aug 16, 2024 | Common Stock | SSaleDisposed | −18,660 | $2.76 | −$51,501.6 | 220,315 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 47,901 | Direct | |
| Aug 15, 2024 | Common Stock | MOption exerciseDisposed | −12,745 | $0.00 | $0 | 35,156 | Direct | |
| Aug 16, 2024 | Common Stock | MOption exerciseDisposed | −18,660 | $0.00 | $0 | 16,496 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.